Nissan Motor Co. is set to reduce production of its popular Rogue SUV in Japan starting next week due to a shortage of semiconductor chips from Dutch supplier Nexperia, a ripple effect of ongoing diplomatic tensions involving the chipmaker. According to a source familiar with the matter, Nissan will cut output by around 900 units at its Kyushu plant in the week beginning November 10. The automaker is also reassessing its production plans for the following week as the shortage persists.
The Rogue, known as the X-Trail in Japan and the U.K., was Nissan’s best-selling vehicle in the United States last year, with nearly 246,000 units sold. While Nissan also manufactures the model in Tennessee, the production cut in Japan highlights the global impact of supply chain disruptions. The company confirmed it will implement “small-scale production adjustments” at its Kyushu and Oppama plants, the latter producing the Note compact car, and emphasized that the situation remains fluid. Nissan stated it will work swiftly to recover and minimize customer delays once chip supplies stabilize. Further updates are expected during its second-quarter earnings announcement on Thursday.
The chip shortage stems from escalating tensions between China and the Netherlands after the Dutch government seized control of Nexperia, citing security concerns over its Chinese parent company, Wingtech. In response, China imposed export bans on Nexperia products, disrupting global automotive supply chains. Although China later suggested possible exemptions, tensions remain high.
Automakers worldwide, including Honda Motor Co., have been forced to adjust or suspend production as a result. Nexperia chips are essential components used in vehicle systems such as brakes, lighting, and entertainment features. Nissan warned that chip supply risks would remain a major challenge in the months ahead, underscoring the automotive industry’s ongoing vulnerability to geopolitical shocks.


SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Apple Turns 50: From Garage Startup to AI Crossroads
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears 



